Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-11-10FDA Approved: PROVOCHOLINE — Supplemental Application (Methapharm Inc.)
The FDA approved a supplemental application for Provocholine (methacholine chloride) from Methapharm Inc., supporting its continued use as a…
-
FDA approval · 2020-11-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, under an ANDA.
-
FDA approval · 2020-11-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited, granting continued approval of a gener…
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma) [Phase 2]
Phase 2 trial investigating vitamin D for preventing severe asthma exacerbations in children; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) [Phase 3]
Long-term safety data from a Phase 3 trial evaluating dupilumab in asthma patients has been completed and results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD) [Phase 2]
Phase 2 repeat-dose study of GSK3772847 in moderate to severe asthma with allergic fungal airway disease was terminated; results posted.
-
FDA approval · 2020-10-22FDA Approved: ALBUTEROL — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original application for ALBUTEROL by Zydus Pharmaceuticals USA Inc., establishing a generic albuterol product.
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, marking approval of a generic montelukast product und…
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, authorizing a generic Montelukast product.
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Montelukast Sodium (ANDA 203432) from Ajanta Pharma USA Inc., granting approval of this generic …
-
CLINICAL_TRIALS research · 2020-10-20Clinical Trial Update: Connected Healthcare for Individuals Living at Home With Chronic Conditions [NA]
Clinical trial update describing connected healthcare for home-based management of chronic conditions; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Improving Asthma Care by Partnering With School Nurses to Bring Asthma Care Into the Inner-City Schools [NA]
A completed trial focusing on improving asthma care by partnering with school nurses to deliver asthma management in inner-city schools; res…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium [Phase 3]
A Phase 3 trial comparing QVM149 to a free triple combination in asthma has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis [Phase 4]
Phase 4 pediatric trial update for Sunovion growth study in children with mild asthma and allergic rhinitis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab". [Phase 4]
Phase 4 trial comparing efficacy of Mepolizumab versus Omalizumab in severe asthma (Choosebetweenamab). Status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563). [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of intravenously administered benralizumab (MEDI-563) in asthma has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment [Phase 3]
Phase 3 trial evaluating safety of QAW039 in asthma patients inadequately controlled on standard therapy; study terminated with posted resul…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth [Phase 4]
Phase 4 trial comparing Flovent Discus, QVAR, and Pulmicort Flexhaler for short-term growth effects in asthma patients; results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Impact of Tiotropium Add-on Therapy in Patients With Asthma
Clinical trial update on tiotropium add-on therapy in asthma patients with completed status and posted results.
-
CLINICAL_TRIALS research · 2020-10-09Clinical Trial Update: Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
A completed clinical trial evaluating errors in the use of metered dose inhalers among patients with asthma and COPD.
-
FDA approval · 2020-10-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application to allow Lannett Company, Inc. to market a generic Montelukast Sodium product (ANDA 200405).
-
FDA approval · 2020-10-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium by Torrent Pharmaceuticals Limited (ANDA 201515).
-
FDA approval · 2020-10-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium, authorizing the regulatory action for th…
-
FDA approval · 2020-09-29FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for ProAir Digihaler (albuterol sulfate) from Teva Respiratory, LLC.
-
FDA approval · 2020-09-29FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for ALBUTEROL SULFATE submitted by Padagis Israel Pharmaceuticals Ltd.